$PCT
PureCycle Technologies, Inc. Stock $pct

$pct Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000183003323000080 Filed on November 09, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$15.18M	$13.17M
YoY Change	30.99%	-8.41%
% of Gross Profit
Research & Development	$5.876M	$178.0K
YoY Change	2278.95%	-29.92%
% of Gross Profit
Depreciation & Amortization	$1.317M	$9.300M
YoY Change	27.86%	933.33%
% of Gross Profit
Operating Expenses	$29.03M	$35.25M
YoY Change	35.39%	67.15%
Operating Profit
YoY Change
Interest Expense	-$10.70M	$10.75M
YoY Change	-692.09%	875.5%
% of Operating Profit
Other Income/Expense, Net	$16.20M	$40.13M
YoY Change	57.64%	-389.54%
Pretax Income	-$23.53M	$4.886M
YoY Change	151.37%	-113.98%
Income Tax	$650.0K	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$24.18M	$4.886M
YoY Change	158.31%	-113.98%
Net Earnings / Revenue
Basic Earnings Per Share		$0.03
Diluted Earnings Per Share	-$0.15	$0.00
COMMON SHARES
Basic Shares Outstanding	164.1M shares	164.0M shares
Diluted Shares Outstanding		165.5M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$121.6M	$211.4M
YoY Change	-25.14%	-1.67%
Cash & Equivalents	$73.41M	$199.3M
Short-Term Investments	$48.23M	$12.03M
Other Short-Term Assets	$41.01M	$45.97M
YoY Change	-44.38%	-56.67%
Inventory	$4.791M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$162.6M	$257.3M
YoY Change	-31.15%	-19.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$638.7M	$625.9M
YoY Change	26.3%	42.71%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$208.2M	$158.5M
YoY Change	107.63%	46.97%
Total Long-Term Assets	$876.7M	$814.5M
YoY Change	40.25%	43.89%
TOTAL ASSETS
Total Short-Term Assets	$162.6M	$257.3M
Total Long-Term Assets	$876.7M	$814.5M
Total Assets	$1.039B	$1.072B
YoY Change	20.67%	20.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.881M	$6.847M
YoY Change	72.83%	-3.56%
Accrued Expenses	$35.39M	$29.82M
YoY Change	0.82%	-8.43%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$9.148M	$7.065M
YoY Change
Total Short-Term Liabilities	$55.61M	$51.97M
YoY Change	45.19%	13.47%
LONG-TERM LIABILITIES
Long-Term Debt	$507.4M	$506.3M
YoY Change	117.29%	117.08%
Other Long-Term Liabilities	$1.811M	$1.185M
YoY Change	59.42%	6.95%
Total Long-Term Liabilities	$1.811M	$1.185M
YoY Change	-99.23%	6.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$55.61M	$51.97M
Total Long-Term Liabilities	$1.811M	$1.185M
Total Liabilities	$619.1M	$630.3M
YoY Change	76.67%	71.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$344.2M	-$320.1M
YoY Change	41.94%	37.27%
Common Stock	$164.0K	$164.0K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$420.2M	$441.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.039B	$1.072B
YoY Change	20.67%	20.83%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$24.18M	$4.886M
YoY Change	158.31%	-113.98%
Depreciation, Depletion And Amortization	$1.317M	$9.300M
YoY Change	27.86%	933.33%
Cash From Operating Activities	-$33.58M	-$20.91M
YoY Change	119.25%	38.72%
INVESTING ACTIVITIES
Capital Expenditures	$11.22M	$18.44M
YoY Change	-85.06%	-121.69%
Acquisitions
YoY Change
Other Investing Activities	-$35.56M	-$12.02M
YoY Change	-158.77%	-116.44%
Cash From Investing Activities	-$46.77M	-$30.46M
YoY Change	220.52%	155.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.275M	219.2M
YoY Change	1348.86%	-42411.78%
NET CHANGE
Cash From Operating Activities	-33.58M	-20.91M
Cash From Investing Activities	-46.77M	-30.46M
Cash From Financing Activities	-1.275M	219.2M
Net Change In Cash	-81.62M	167.8M
YoY Change	172.13%	-709.49%
FREE CASH FLOW
Cash From Operating Activities	-$33.58M	-$20.91M
Capital Expenditures	$11.22M	$18.44M
Free Cash Flow	-$44.80M	-$39.35M
YoY Change	-50.45%	-156.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Operating Expenses OperatingExpenses	84869000	usd
	us-gaap	Operating Expenses OperatingExpenses	59874000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	641000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-25842000	usd
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	164059311	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199349000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63892000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	12026000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	33277000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	68850000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12689000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4883000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	257341000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	236217000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	151513000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	94781000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	625925000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	505719000	usd
CY2023Q3	us-gaap	Assets Assets	1071833000	usd
CY2022Q4	us-gaap	Assets Assets	861336000	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	6847000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35102000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	7065000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2023Q3	us-gaap	Interest Payable Current InterestPayableCurrent	8230000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1532000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	51966000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38301000	usd
CY2023Q3	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	38214000	usd
CY2022Q4	pct	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	55883000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27556000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16620000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1185000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164059000	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	164000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	164000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	753885000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-641000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320057000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-242525000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	441566000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	510883000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1071833000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	861336000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	16948000	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	178000	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	254000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	731000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	843000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13172000	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14382000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	39725000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42083000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	35247000	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	21087000	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163490000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163783000	shares
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001830033
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2021Q1	pct	Derivative Instrument Contingent Consideration Liability Earnout Period Business Days Prior To Notice Of Redemption DerivativeInstrumentContingentConsiderationLiabilityEarnoutPeriodBusinessDaysPriorToNoticeOfRedemption	P3D
CY2023Q3	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	PureCycle Technologies, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5950 Hazeltine National Drive,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Orlando
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32822
	dei	City Area Code CityAreaCode	877
	dei	Local Phone Number LocalPhoneNumber	648-3565
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	98592000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	7004000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Noncurrent PrepaidExpenseAndOtherAssetsNoncurrent	5483000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30050000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19136000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1667000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29824000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5000000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5000000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1136000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	630267000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	350453000	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	164059000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163550000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163550000	shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	761466000	usd
CY2023Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	21897000	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6451000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	44413000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	10750000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	159000	usd
	us-gaap	Interest Expense InterestExpense	14883000	usd
	us-gaap	Interest Expense InterestExpense	1197000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2117000	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1261000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	5077000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2031000	usd
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-48817000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	14884000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17669000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	16224000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-51000	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-79000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-526000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-120000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40133000	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13861000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	7337000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	4886000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-34948000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-77532000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164018000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153513000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165548000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163490000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163980000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153699000	shares
CY2023Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	634000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-800000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4879000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-34934000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-76898000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-76184000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	510883000	usd
CY2023Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	277000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2166000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	487571000	usd
CY2023Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	27000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3252000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-56576000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	434220000	usd
CY2023Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	818000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3285000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-7000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	4886000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	441566000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	381535000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	205296000	usd
CY2022Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1049000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3171000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-340000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-25432000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	563181000	usd
CY2022Q2	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	17000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3267000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-460000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-15004000	usd
CY2022Q3	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	506000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3010000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	14000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-34948000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	518537000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-77532000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8703000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	9448000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17669000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	16224000	usd
	us-gaap	Interest Paid Net InterestPaidNet	2736000	usd
	us-gaap	Depreciation Depreciation	14618000	usd
	us-gaap	Depreciation Depreciation	2583000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1840000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	746000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	149000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	235000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2171000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	964000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	5957000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Current IncreaseDecreaseInPrepaidExpensesAndOtherAssetsCurrent	3320000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	1523000	usd
	pct	Increase Decrease In Prepaid Expenses And Other Assets Noncurrent IncreaseDecreaseInPrepaidExpensesAndOtherAssetsNoncurrent	1296000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1527000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	827000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	4375000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	491000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	9867000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	324000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1601000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1536000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61330000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-50164000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	142680000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	212095000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	12020000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	192388000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	99371000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	200689000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55329000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-203794000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	225000000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	38000000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	usd
	pct	Proceeds From Equipment Lease Financing ProceedsFromEquipmentLeaseFinancing	22101000	usd
	pct	Proceeds From Equipment Lease Financing ProceedsFromEquipmentLeaseFinancing	0	usd
	pct	Payments Of Convertible Notes Issuance Costs PaymentsOfConvertibleNotesIssuanceCosts	6498000	usd
	pct	Payments Of Convertible Notes Issuance Costs PaymentsOfConvertibleNotesIssuanceCosts	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1122000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1572000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-257000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-36000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	206072000	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	43929000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	775000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	273275000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	247618000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	156616000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6340000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	227523000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263858000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	384139000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	257518000	usd
	us-gaap	Interest Paid Net InterestPaidNet	650000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
	pct	Additions To Property Plant And Equipment In Accrued Expenses AdditionsToPropertyPlantAndEquipmentInAccruedExpenses	16152000	usd
	pct	Additions To Property Plant And Equipment In Accrued Expenses AdditionsToPropertyPlantAndEquipmentInAccruedExpenses	22059000	usd
	pct	Additions To Property Plant And Equipment In Accounts Payable AdditionsToPropertyPlantAndEquipmentInAccountsPayable	4470000	usd
	pct	Additions To Property Plant And Equipment In Accounts Payable AdditionsToPropertyPlantAndEquipmentInAccountsPayable	3267000	usd
	pct	Additions To Property Plant And Equipment In Accrued Interest AdditionsToPropertyPlantAndEquipmentInAccruedInterest	0	usd
	pct	Additions To Property Plant And Equipment In Accrued Interest AdditionsToPropertyPlantAndEquipmentInAccruedInterest	4271000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	1745000	usd
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	usd
CY2021Q1	pct	Business Combination Contingent Consideration Liability Shares Maximum Issued BusinessCombinationContingentConsiderationLiabilitySharesMaximumIssued	4000000	shares
CY2021Q1	pct	Business Combination Contingent Consideration Liability Shares BusinessCombinationContingentConsiderationLiabilityShares	2000000	shares
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period BusinessCombinationContingentConsiderationLiabilityEarnoutPeriod	P1Y
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period Stock Price Trigger BusinessCombinationContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period Threshold Trading Days BusinessCombinationContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	tradingday
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period Threshold Trading Day Period BusinessCombinationContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	tradingday
CY2021Q1	pct	Business Combination Contingent Consideration Liability Shares BusinessCombinationContingentConsiderationLiabilityShares	2000000	shares
CY2022Q1	pct	Business Combination Acquisition Related Costs Advisory Legal And Accounting BusinessCombinationAcquisitionRelatedCostsAdvisoryLegalAndAccounting	800000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	199349000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	63892000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	12026000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	98592000	usd
CY2023Q3	pct	Unrestricted Liquidity Amount UnrestrictedLiquidityAmount	211375000	usd
CY2022Q4	pct	Unrestricted Liquidity Amount UnrestrictedLiquidityAmount	162484000	usd
CY2023Q3	pct	Expected Investment To Complete Facility Current Fiscal Year Amount Set Aside In Restricted Cash ExpectedInvestmentToCompleteFacilityCurrentFiscalYearAmountSetAsideInRestrictedCash	0	usd
CY2022Q4	pct	Expected Investment To Complete Facility Current Fiscal Year Amount Set Aside In Restricted Cash ExpectedInvestmentToCompleteFacilityCurrentFiscalYearAmountSetAsideInRestrictedCash	54560000	usd
CY2023Q3	pct	Available Unrestricted Liquidity Amount AvailableUnrestrictedLiquidityAmount	211375000	usd
CY2022Q4	pct	Available Unrestricted Liquidity Amount AvailableUnrestrictedLiquidityAmount	107924000	usd
CY2023Q3	us-gaap	Restricted Cash RestrictedCash	184790000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	163631000	usd
CY2023Q3	pct	Working Capital WorkingCapital	205375000	usd
CY2022Q4	pct	Working Capital WorkingCapital	197916000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-320057000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-242525000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-77532000	usd
CY2023Q3	pct	Available Unrestricted Liquidity Amount AvailableUnrestrictedLiquidityAmount	211400000	usd
CY2023Q3	pct	Common Stock Number Of Votes For Each Share Held CommonStockNumberOfVotesForEachShareHeld	1	vote
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000.0	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	164060000.00	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	164060000.00	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	163550000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	163550000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000.0	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.90
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M12D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.90
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	613000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.90
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	459000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.72
	pct	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P10Y
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	5000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.72
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1067000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	19.03
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	613000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	186000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1135000	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q1	pct	Class Of Warrant Or Right Redemption Price Of Warrants Or Rights ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights	0.01
CY2021Q1	pct	Class Of Warrant Or Right Redemption Of Warrants Or Rights Written Notice Of Redemption Threshold ClassOfWarrantOrRightRedemptionOfWarrantsOrRightsWrittenNoticeOfRedemptionThreshold	P30D
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period Stock Price Trigger BusinessCombinationContingentConsiderationLiabilityEarnoutPeriodStockPriceTrigger	18.00
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period Threshold Trading Days BusinessCombinationContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDays	20	tradingday
CY2021Q1	pct	Business Combination Contingent Consideration Liability Earnout Period Threshold Trading Day Period BusinessCombinationContingentConsiderationLiabilityEarnoutPeriodThresholdTradingDayPeriod	30	tradingday
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	4886000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-34948000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-77532000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
CY2023Q3	us-gaap	Warrant Down Round Feature Decrease In Net Income Loss To Common Shareholder Amount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount	480000	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4406000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-34948000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-77532000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-75384000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164018000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163490000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163783000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153513000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.49
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	4886000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-34948000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-77532000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75384000	usd
CY2023Q3	pct	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfWarrants	4049000	usd
CY2022Q3	pct	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfWarrants	0	usd
	pct	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfWarrants	1485000	usd
	pct	Dilutive Securities Effect On Basic Earnings Per Share Change In Fair Value Of Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareChangeInFairValueOfWarrants	553000	usd
CY2023Q3	pct	Dilutive Securities Effect On Basic Earnings Per Share Income Attributable To Participating Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareIncomeAttributableToParticipatingWarrants	81000	usd
CY2022Q3	pct	Dilutive Securities Effect On Basic Earnings Per Share Income Attributable To Participating Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareIncomeAttributableToParticipatingWarrants	0	usd
	pct	Dilutive Securities Effect On Basic Earnings Per Share Income Attributable To Participating Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareIncomeAttributableToParticipatingWarrants	0	usd
	pct	Dilutive Securities Effect On Basic Earnings Per Share Income Attributable To Participating Warrants DilutiveSecuritiesEffectOnBasicEarningsPerShareIncomeAttributableToParticipatingWarrants	0	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	756000	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-34948000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-79017000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-75937000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	164018000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163490000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163783000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	153513000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	395000	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	197000	shares
CY2022Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	165548000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163490000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	163980000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	153699000	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.49
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	649119000	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	23194000	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	625925000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	514317000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8598000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	505719000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	9300000	usd
	us-gaap	Depreciation Depreciation	14600000	usd
CY2022Q3	us-gaap	Depreciation Depreciation	900000	usd
	us-gaap	Depreciation Depreciation	2600000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	12033000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	12026000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	99234000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	642000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	98592000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	12033000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	12026000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis	92253000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	91669000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	0	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	0	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveAmortizedCostBasis	6981000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	6923000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	12033000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	12026000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Current DebtSecuritiesAvailableForSaleAmortizedCostCurrent	99234000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	98592000	usd
CY2023Q3	pct	Debt Securities Weighted Average Remaining Maturity DebtSecuritiesWeightedAverageRemainingMaturity	P0Y3M18D
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
	us-gaap	Debt Securities Available For Sale Realized Loss DebtSecuritiesAvailableForSaleRealizedLoss	0	usd
CY2021Q2	pct	Loss Contingency Number Of Class Actions LossContingencyNumberOfClassActions	2	classaction
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P15Y
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	52300000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P30Y
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	27700000	eur
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1252000	usd
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	618000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	3042000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1390000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	211000	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	83000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	795000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	291000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	1463000	usd
CY2022Q3	us-gaap	Lease Cost LeaseCost	701000	usd
	us-gaap	Lease Cost LeaseCost	3837000	usd
	us-gaap	Lease Cost LeaseCost	1681000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2687000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1829000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	13084000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8266000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y3M18D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y10M24D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.047
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	30050000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19136000	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2446000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2188000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	27556000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16620000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	30002000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	18808000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	813000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4495000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4551000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	4457000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4054000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	2814000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	29347000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	50531000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	20529000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	30002000	usd
CY2023Q2	pct	Sale Leaseback Transaction Number Of Land SaleLeasebackTransactionNumberOfLand	150	acre
CY2023Q2	pct	Sale Leaseback Transaction Estimated Cost SaleLeasebackTransactionEstimatedCost	440000000	usd
CY2023Q3	pct	Sale Leaseback Transaction Amount Invested To Date SaleLeasebackTransactionAmountInvestedToDate	77000000	usd
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
pct-20230930_cal.xml	Edgar Link	unprocessable
pct-20230930_def.xml	Edgar Link	unprocessable
0001830033-23-000080-index-headers.html	Edgar Link	pending
0001830033-23-000080-index.html	Edgar Link	pending
0001830033-23-000080.txt	Edgar Link	pending
0001830033-23-000080-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pct-20230930.htm	Edgar Link	pending
pct-20230930.xsd	Edgar Link	pending
pct-20230930_g1.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pct-20230930_htm.xml	Edgar Link	completed
pct-20230930_lab.xml	Edgar Link	unprocessable
pct-20230930_pre.xml	Edgar Link	unprocessable
pct-form10xqex104q32023pur.htm	Edgar Link	pending
pct-form10xqex311q32023.htm	Edgar Link	pending
pct-form10xqex312q32023.htm	Edgar Link	pending
pct-form10xqex321q32023.htm	Edgar Link	pending
pct-form10xqex322q32023.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCT
PureCycle Technologies, Inc. Stock $pct

2023 Q4 Form 10-Q Financial Statement

#000183003323000080 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT PureCycle Technologies, Inc. Stock $pct

2023 Q4 Form 10-Q Financial Statement

#000183003323000080 Filed on November 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCT
PureCycle Technologies, Inc. Stock $pct